Bain Capital Public Equity Management II’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-65,700
Closed -$7.36M 55
2021
Q4
$7.36M Sell
65,700
-126,800
-66% -$15.3M 0.25% 39
2021
Q3
$24.2M Buy
192,500
+187,675
+3,890% +$24.2M 0.85% 30
2021
Q2
$399K Buy
4,825
+825
+21% +$108K 0.02% 43
2021
Q1
$800K Buy
+4,000
New +$599K 0.03% 55
2020
Q4
Sell
-3,500
Closed -$1.01M 57
2020
Q3
$1.01M Buy
3,500
+2,250
+180% +$252K 0.07% 36
2020
Q2
$346K Sell
1,250
-2,250
-64% -$222K 0.03% 42
2020
Q1
$536K Buy
+3,500
New +$310K 0.06% 37
2019
Q4
Sell
-6,660
Closed -$1.24M 57
2019
Q3
$1.24M Buy
6,660
+3,880
+140% +$322K 0.12% 44
2019
Q2
$272K Buy
+2,780
New +$237K 0.03% 51

Other funds holding XBI